Table 2 Laboratory baseline findings and underlying heart diseases of the study population
From: Epidemiology and long-term prognosis of atrial fibrillation in rural African patients
Parameter | Value |
|---|---|
Serum glucose (mmol/l), mean ± SD | 4.68 ± 1.31 |
Hemoglobin (g/dl), mean ± SD | 11.74 ± 1.97 |
Serum creatinine (μmol/l), mean ± SD | 123.1 ± 56.48 |
eGFR (ml/min/1.73 m2), mean ± SD | 61.67 ± 24.66 |
Uric acid (μmol/l), mean ± SD | 387.81 ± 101.54 |
Serum potassium (mmol/l), mean ± SD | 3.97 ± 0.49 |
Serum calcium (mmol/l), mean ± SD | 2.1 ± 0.23 |
Sodium (mmol/l), mean ± SD | 135.55 ± 8.28 |
QRS duration (milliseconds), mean ± SD | 110.35 ± 9.28 |
Left bundle block branch, n (%) | 13 (12.87) |
Left atrium diameter (mm), mean ± SD | 46.04 ± 7.06 |
Left atrium surface (cm2), mean ± SD | 23.73 ± 6.50 |
LVEF (%), mean ± SD | 41.4 ± 17 |
LVEF < 40%, n (%) | 60 (59.41) |
LVEF = 40–49%, n (%) | 9 (8.91) |
LVEF ≥ 50%, n (%) | 32 (31.68) |
Left ventricular filling pressure (E/E’), mean ± SD | 14.68 ± 4.65 |
Left ventricular diastolic dysfunction, n (%) | 75 (74.26) |
Heart diseases and etiologies | |
Hypertensive heart disease, n (%) | 46 (45.54) |
Idiopathic dilated cardiomyopathy, n (%) | 21 (20.79) |
Valvular heart disease, n (%) | 10 (9.90) |
Restrictive cardiomyopathy, n (%) | 8 (7.92) |
Ischemic heart disease, n (%) | 6 (5.94) |
Hyperthyroidism, n (%) | 3 (2.97) |
Lone AF, n (%) | 7 (6.90) |